Last reviewed · How we verify
ketofol
At a glance
| Generic name | ketofol |
|---|---|
| Also known as | a mixture of propofol and ketamine, single-syringe ketamine-propofol 1:1 combination, Ketamine-Propofol, Ketamine and Propofol, Ketalar |
| Sponsor | Zagazig University |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Ketodex Versus Ketofol in Adolescent Gastrointestinal Endoscopy
- Comparison of the Hemodynamic Effects of Ketamine - Dexmedetomidine (Ketodex) Versus Propofol-ketamine Admixture (Ketofol) During Induction of Anesthesia in Elderly: A Randomized Comparative Study (NA)
- Effects of Different Sedation Techniques on Early Cognitive Recovery After Ambulatory Gynecologic Surgery (NA)
- Comparison of Propofol and Ketofol as Induction Agents for Electroconvulsive Therapy (NA)
- Best Hypnotic Drug Choice for Rapid Sequence Induction in the Operating Room (PHASE3)
- Comparison of Esketamine/Propofol and Methohexital Anesthesia for ECT (PHASE4)
- Oropharyngeoesophageal Topical Anesthesia Versus Propofol - Ketamine Sedation for Upper Gastrointestinal Endoscopy (NA)
- Ketofol Versus Dexmedetomidine for Prevention of Emergence Delirium in Pediatric Patients Undergoing Squint Surgeries (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ketofol CI brief — competitive landscape report
- ketofol updates RSS · CI watch RSS
- Zagazig University portfolio CI